Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Quote. Delayed Nasdaq - 02/21 04:00:00 pm
51.45 USD   -0.81%
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/18WALGREENS BOOTS ALLIANCE : Ex-dividend day for
FA
02/13CVS Reaps Benefits of Aetna Deal -- WSJ
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
52.85(c) 51.86(c) 52.07(c) 51.87(c) 51.45(c) Last
5 153 820 4 334 648 3 279 683 3 368 565 4 637 944 Volume
-1.34% -1.87% +0.40% -0.38% -0.81% Change
More quotes
Financials (USD)
Sales 2020 140 B
EBIT 2020 6 485 M
Net income 2020 4 014 M
Debt 2020 14 815 M
Yield 2020 3,58%
Sales 2021 144 B
EBIT 2021 6 649 M
Net income 2021 4 374 M
Debt 2021 13 381 M
Yield 2021 3,73%
P/E ratio 2020 11,3x
P/E ratio 2021 10,1x
EV / Sales2020 0,43x
EV / Sales2021 0,41x
Capitalization 45 578 M
More Financials
Company
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (83.4%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and... 
Sector
Drug Retailers
Calendar
04/07Earnings Release
More about the company
Surperformance© ratings of Walgreens Boots Alliance,
Trading Rating : Investor Rating :
More Ratings
Latest news on WALGREENS BOOTS ALLIANCE,
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/18WALGREENS BOOTS ALLIANCE : Ex-dividend day for
FA
02/13CVS Reaps Benefits of Aetna Deal -- WSJ
DJ
02/12CVS Swings to Profit, Forecasts 2020 Results in Line With Estimates -- Update
DJ
02/12CVS HEALTH : Turns Quarterly Profit, Posts Higher Revenue
DJ
02/11CHAMPIONING GLOBAL HEALTH : Walgreens Boots Alliance New Global Sustainability R..
BU
02/06WALGREENS BOOTS ALLIANCE : Southern States Dominate the Walgreens Flu Index Top ..
AQ
02/06WALGREENS BOOTS ALLIANCE : Initial Statement of Beneficial Ownership
PU
02/05WALGREENS BOOTS ALLIANCE : Names Richard Ashworth President of Walgreens
DJ
02/05WALGREENS BOOTS ALLIANCE : Appoints Richard Ashworth President of Walgreens
BU
02/05WALGREENS BOOTS ALLIANCE : TCS-Walgreens Boots Alliance Advances Transformation ..
AQ
02/05WALGREENS BOOTS ALLIANCE : Southern States Dominate the Walgreens Flu Index® Top..
BU
02/04MCKESSON : Revenue Misses Expectations, Adjusted Earnings Beat
DJ
02/04WALGREENS BOOTS ALLIANCE, INC. : Submission of Matters to a Vote of Security Hol..
AQ
02/04DAVID DORMAN : CVS Pushes Out Player in Aetna Deal -- WSJ
DJ
More news
News in other languages on WALGREENS BOOTS ALLIANCE,
02/18WALGREENS BOOTS ALLIANCE : Ex-dividend day for
01/09Aktien New York Schluss: Dow marschiert Richtung 29 000 Punkte
01/09Aktien New York: Gelöste Stimmung - Dow marschiert Richtung 29 000 Punkte
01/09Aktien New York: Schon wieder Rekorde - Nächstes Dow-Ziel 29 000 Punkte
01/08Wall Street finit en hausse après le discours rassurant de Trump
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE,
More recommendations
Sector news : Drug Retailers - NEC
02/22Tesla resumes tree cutting in Germany to build Gigafactory
RE
02/21RAG foundation wants "significant minority stake" in Thyssen's lift unit-repo..
RE
02/21Report Saudi Arabia to break from OPEC+ alliance is 'nonsense' - Saudi Energy..
RE
02/20Credit Suisse investment group buys NorthPoint Technology
RE
02/20Lebanon's Bank Audi collects $210 million for capital increase
RE
More sector news : Drug Retailers - NEC
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE,
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 56,35  $
Last Close Price 51,45  $
Spread / Highest target 26,3%
Spread / Average Target 9,52%
Spread / Lowest Target -12,5%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
James Kehoe Global Chief Financial Officer & Executive VP
Sector and Competitors